Effects of Zinc supplementation in obesity
Not Applicable
- Conditions
- obesity.Localized adiposity, ObesityE65, E66
- Registration Number
- IRCT2015072615968N2
- Lead Sponsor
- ational Nutrition and Food Technology Research Institute
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 50
Inclusion Criteria
aged 45-18 years; non-smoking; body mass index above 30 kg/m2
Exclusion criteria: pregnancy; lactation; menopause in women; a history of liver disease; kidney disease; thyroid; diabetes and other metabolic diseases; drugs interfering with lipid profile; blood-thinning drugs; beta-blockers; patients with immune deficiency; zinc supplementation; calcium and iron in 2 months; use of weight loss drugs or diet; weight loss diet in the last 2 months; recent surgery
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Body mass Index. Timepoint: before intervention, seven weeks after intervention,fifteen weeks after intervention. Method of measurement: calculating.;Weight. Timepoint: before intervention, seven weeks after intervention,fifteen weeks after intervention. Method of measurement: Seca scale.;Waist circumference. Timepoint: before intervention, seven weeks after intervention,fifteen weeks after intervention. Method of measurement: meter.;Hip circumference. Timepoint: before intervention, seven weeks after intervention,fifteen weeks after intervention. Method of measurement: meter.;Waist circumference to hip ratio. Timepoint: before intervention, seven weeks after intervention,fifteen weeks after intervention. Method of measurement: calculating.;Body fat percentage. Timepoint: before intervention, seven weeks after intervention,fifteen weeks after intervention. Method of measurement: Bioelectrical Impedance Analysis.
- Secondary Outcome Measures
Name Time Method Serum TNF-alpha concentration. Timepoint: before intervention,fifteen weeks after intervention. Method of measurement: Enzymatic method by kit.;Hs-CRP concentration. Timepoint: before intervention,fifteen weeks after intervention. Method of measurement: Enzymatic method by kit.;Apelin concentration. Timepoint: before intervention,fifteen weeks after intervention. Method of measurement: Enzymatic method by kit.